PharmiWeb.com - Global Pharma News & Resources
21-Oct-2024

Global Medical Hyperspectral Imaging Market Set to Reach USD 294.7 Million by 2030

The global medical hyperspectral imaging market is on an upward trajectory, with projections indicating a substantial growth from USD 181.8 million in 2022 to an impressive USD 294.7 million by 2030. This represents a robust Compound Annual Growth Rate (CAGR) of 6.2%, highlighting the increasing significance of hyperspectral imaging technology within modern healthcare.

Hyperspectral imaging, which currently constitutes 0.4% of the global medical imaging equipment market, is rapidly gaining traction due to its advanced capabilities in solid tumor detection and diagnosis. By integrating spectroscopy with imaging, this innovative technology allows for the simultaneous capture of spectral and spatial data from tissues, providing a non-invasive method that significantly enhances diagnostic accuracy and treatment planning.

“This growth trajectory underscores the transformative impact of hyperspectral imaging on healthcare, particularly in the field of oncology,” stated a representative from Future Market Insights. “The capability to analyze tissue composition in real-time is revolutionizing the way clinicians detect and monitor diseases, ultimately leading to improved patient outcomes.”

The rising adoption of hyperspectral imaging among medical institutions can be attributed to its potential to deliver detailed insights into tissue physiology, facilitating early disease detection and the development of personalized treatment strategies. As healthcare providers continue to prioritize advanced imaging technologies, hyperspectral imaging stands out for its ability to enhance clinical decision-making and streamline workflow efficiencies.

As the market evolves, stakeholders are encouraged to recognize the opportunities presented by hyperspectral imaging, paving the way for innovations that could redefine the standards of care in oncology and beyond.

Key Takeaways: Medical Hyperspectral Imaging Market Growth

  • The global medical hyperspectral imaging market is expected to grow significantly, reaching a valuation of USD 294.7 million by 2030, expanding at a CAGR of 6.2%.
  • North America currently holds the largest market share (35.4%) due to early adoption and strong healthcare investment.
  • Europe follows closely behind with a 27.3% share, driven by advanced research infrastructure and technology.
  • The Asia Pacific region (South, East, and Oceania) is projected to experience significant growth (26.2% share) due to rising adoption and success in developed nations.
  • Latin America and the Middle East & Africa are expected to see smaller but increasing market shares (6% and 5.1% respectively) as they develop their healthcare infrastructure.

Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!

Competitive Landscape:

Market participants can enhance their production and align with consumer needs by forming strategic partnerships, thereby bolstering profitability and market presence. Manufacturers innovate across diverse technological fronts to both augment revenues and expand market influence.

  • Rio Tinto, in a recent collaboration with a satellite start-up, now utilizes satellites capable of generating hyperspectral images of mine sites from a distance of 5 meters. This advancement enables the company to efficiently monitor both active and decommissioned mining locations, track Environmental, Social, and Governance (ESG) metrics, and advance exploration efforts.
  • Meanwhile, Cubert GmBH unveiled the HIS-ULTRIS 5, a compact Hyperspectral Video Imager employing Light Field Technology, in October 2021.

Key Companies Profiled:

  • IMEC
  • Norsk Elektro Optikk
  • Galileo
  • Gilden Photonics
  • Resonon
  • XIMEA
  • Gooch & Housego
  • Chemlmage
  • Applied Spectral Imaging
  • Cubert
  • EVK DI Kerschhaggl
  • Headwall Photonics
  • FluxData

Key Segments of Medical Hyperspectral Imaging Industry Survey:

Medical Hyperspectral Imaging Market by Product:

  • Hyperspectral Imaging Systems
  • Hyperspectral Imaging Accessories

Medical Hyperspectral Imaging Market by Application:

  • Medical Diagnosis
  • Tissue and Cell Biology
  • Drug Discovery
  • Others

Medical Hyperspectral Imaging Market by Technology:

  • Visible Hyperspectral Imaging
  • Near-infrared Hyperspectral Imaging
  • Ultraviolet Hyperspectral Imaging
  • Short-wave Infrared Imaging
  • Mid-wave Infrared Hyperspectral Imaging

Medical Hyperspectral Imaging Market by End User:

  • Diagnostic Centres
  • Hospitals
  • Research & Academic Centres
  • Pharmaceutical & Biotechnology Companies

Medical Hyperspectral Imaging Market by Region:

  • North America Medical Hyperspectral Imaging Market
  • Latin America Medical Hyperspectral Imaging Market
  • Europe Medical Hyperspectral Imaging Market
  • East Asia Medical Hyperspectral Imaging Market
  • South Asia & Pacific Medical Hyperspectral Imaging Market
  • Middle East & Africa (MEA) Medical Hyperspectral Imaging Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 21-Oct-2024